Boy's rare form of muscular dystrophy approved but not available in BC

A British Columbia mother is advocating for a national rare disease strategy to improve access to life-saving medications for children like her son, who has Duchenne muscular dystrophy. Despite international approvals, the family struggles to access specific treatments, highlighting gaps in the Canadian healthcare system.
Why it matters
It underscores the systemic challenges families face in accessing specialized medical treatments for rare genetic conditions in Canada.
Copy Link Email X Reddit Pinterest LinkedIn Tumblr 'Is this the best we can do?': B.C. mom of boy with muscular dystrophy calls for rare disease strategy Kasha Mitton says kids with rare degenerative diseases shouldn't have to wait for drugs that have already been approved by Health Canada and other countries
Join the conversation Kasha Mitton with her husband Jeff and son Jude. Jude has a rare genetic disease called Duchenne muscular dystrophy. The Kamloops family is calling for a national strategy for rare disease so they can access approved treatment faster. Article content Kasha Mitton, a Kamloops nurse, knew something wasn’t right when her son Jude was delayed in crawling and then walking.
Create an account or sign in to continue with your reading experience.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in